Dideoxynucleosides
Showing 1 - 25 of 38
HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg
Completed
- HIV-1-infection
- abacavir, dolutegravir and lamivudine dispersible tablets
- Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
-
Montréal, Quebec, CanadaAltasciences
Mar 10, 2022
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)
Recruiting
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Dexamethasone
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
HIV, Peripheral Nervous System Diseases Trial in Puerto Rico, United States (Acetyl-L-carnitine)
Completed
- HIV Infections
- Peripheral Nervous System Diseases
-
Palo Alto, California
- +10 more
Oct 28, 2021
Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))
Active, not recruiting
- Graft Vs Host Disease
- Fluorothymidine (FLT)
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Mar 21, 2022
Malignant Tumor Trial in Salt Lake City ([F-18]fluorodeoxyglucose, [F-18]fluorothymidine, Positron Emission Tomography)
Terminated
- Malignant Neoplasm
- [F-18]fluorodeoxyglucose
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Sep 20, 2021
Infection, Human Immunodeficiency Virus I, HIV Infection Trial in Worldwide (abacavir/lamivudine, abacavir, lamivudine)
Completed
- Infection, Human Immunodeficiency Virus I
- HIV Infection
- abacavir/lamivudine
- +2 more
-
Phoenix, Arizona
- +55 more
Mar 20, 2020
HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)
Infection, Human Immunodeficiency Virus I, HIV Infection Trial in Worldwide (abacavir/lamivudine, abacavir, lamivudine)
Completed
- Infection, Human Immunodeficiency Virus I
- HIV Infection
- abacavir/lamivudine
- +3 more
-
Los Angeles, California
- +75 more
Mar 20, 2020
HIV Infection Trial in Modena (abacavir/lamivudine + raltegravir, abacavir/lamivudine + darunavir/ritonavir)
Completed
- HIV Infection
- abacavir/lamivudine + raltegravir
- abacavir/lamivudine + darunavir/ritonavir
-
Modena, ItalyUniversity of Modena and Reggio Emilia
Apr 19, 2019
HIV Trial in Nairobi (AZT/3TC/NVP (zidovudine/lamivudine/nevirapine), d4T/3TC/NVP (stavudine/lamivudine/nevirapine), AZT/3TC/ABC
Terminated
- HIV Infections
- AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)
- +6 more
-
Nairobi, KenyaKenyatta National Hospital, University of Nairobi
Jul 27, 2018
Infection, Human Immunodeficiency Virus I Trial in Worldwide (Dolutegravir, Atripla, Abacavir/Lamivudine)
Completed
- Infection, Human Immunodeficiency Virus I
- Dolutegravir
- +5 more
-
Hobson City, Alabama
- +144 more
Mar 8, 2018
Recurrent Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial
Completed
- Recurrent Non-Small Cell Lung Carcinoma
- +5 more
- Cisplatin
- +6 more
-
Baltimore, Maryland
- +1 more
Jan 27, 2017
Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in United States (CT, 18F-FLT, PET)
Completed
- Stage IIB Breast Cancer
- +3 more
- CT
- +2 more
-
Scottsdale, Arizona
- +26 more
Dec 28, 2016
MARCH Central Nervous System Substudy
Completed
- HIV-1 Infection
- Arm 1 TNucleotide Analogue Reverse Transcriptase Inhibitors and Boosted Protease Inhibitors
- +2 more
-
Buenos Aires, Argentina
- +5 more
Jan 18, 2016
Proteinuria, HIV Trial in Worldwide (arm 1 nucleotide analogue reverse transcriptase inhibitors and boosted protease inhibitors,
Completed
- Proteinuria
- HIV
- arm 1 nucleotide analogue reverse transcriptase inhibitors and boosted protease inhibitors
- +2 more
-
Buenos Aires, Ciudad de Buenos Aires, Argentina
- +14 more
Jan 18, 2016
HIV/AIDS, Antiretroviral Therapy, HIV Trial in Rome (tenofovir emtricitabine raltegravir, Lamivudine Abacavir Raltegravir,
Completed
- HIV/AIDS
- +2 more
- tenofovir emtricitabine raltegravir
- +2 more
-
Rome, ItalyPoliclinico A. Gemelli
Feb 3, 2015
AIDS-related Kaposi's Sarcoma Trial in Harare (abacavir/3TC/zidovudine, abacavir /3TC plus ritonavir boosted lopinavir)
Completed
- AIDS-related Kaposi's Sarcoma
- abacavir/3TC/zidovudine
- abacavir /3TC plus ritonavir boosted lopinavir
-
Harare, ZimbabweUniversity of Zimbabwe College of Health Sciences Department of
Oct 29, 2014
HIV Trial (Alovudine - low, Alovudine - medium, Alovudine - high)
Completed
- HIV Infections
- Alovudine - low
- +3 more
- (no location specified)
Sep 4, 2014
HIV Infection Trial in Worldwide (Intervention 1: PK assessment while on Twice Daily Abacavir, Intervention 2: PK assessment
Completed
- HIV Infection
- Intervention 1: PK assessment while on Twice Daily Abacavir
- Intervention 2: PK assessment while on Once Daily Abacavir
-
Paris, France
- +9 more
Feb 3, 2014
HIV Trial in Puerto Rico, United States (Abacavir sulfate, Abacavir sulfate, lamivudine, and zidovudine)
Completed
- HIV Infections
- Abacavir sulfate
- Abacavir sulfate, lamivudine, and zidovudine
-
Alhambra, California
- +19 more
Oct 4, 2013